Skip to main content
. Author manuscript; available in PMC: 2015 Sep 4.
Published in final edited form as: Patient Educ Couns. 2012 Sep 28;89(2):345–352. doi: 10.1016/j.pec.2012.08.014

Table 3.

Information need category endorsements by cancer site

Total (n = 1197)
% (95% CI)
Breast (n = 292)
% (95% CI)
Prostate (n = 289)
% (95% CI)
Colorectal (n = 305)
% (95% CI)
Gynecologic (n = 311)
% (95% CI)
Side effects and symptoms 75.8 (72.1, 79.1) 77.2 (69.5, 83.4) 83.1 (76.8, 88.0) 61.9 (53.6, 69.6)* 76.1 (67.7, 82.8)
Tests and treatments 71.5 (67.5, 75.2) 71.7 (63.6, 78.5) 78.0 (70.2, 84.1) 60.8 (52.5, 68.5) 71.3 (62.7, 78.6)
Health promotion 64.5 (60.3, 68.4) 66.4 (58.3, 73.6) 72.4 (64.5, 79.1) 50.9 (43.0, 58.9)* 62.3 (53.1, 70.6)
Interpersonal and emotional 60.2 (56.0, 64.2) 63.6 (55.7, 70.9) 64.7 (56.5, 72.1) 46.0 (38.5, 53.8)* 64.2 (55.6, 72.0)
Insurance 39.0 (35.0, 43.1) 40.1 (33.0, 47.6) 44.0 (35.8, 52.5) 30.3 (23.9, 37.5) 38.0 (30.9, 45.6)
Sexual functioning and fertility 34.5 (30.6, 38.7) 22.1 (16.5, 29.0)* 54.7 (46.1, 63.0)* 22.5 (16.6, 29.8)* 23.7 (18.3, 30.2)*
*

Significantly different from total (P < 0.05).